<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">SCV</journal-id>
<journal-id journal-id-type="hwp">spscv</journal-id>
<journal-id journal-id-type="nlm-ta">Semin Cardiothorac Vasc Anesth</journal-id>
<journal-title>Seminars in Cardiothoracic and Vascular Anesthesia</journal-title>
<issn pub-type="ppub">1089-2532</issn>
<issn pub-type="epub">1940-5596</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1089253213488947</article-id>
<article-id pub-id-type="publisher-id">10.1177_1089253213488947</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Congenital Cardiac Forum</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Surgical Considerations in the Management of Hypoplastic Left Heart Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Shillingford</surname><given-names>Michael</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1089253213488947">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ceithaml</surname><given-names>Eric</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1089253213488947">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Bleiweis</surname><given-names>Mark</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1089253213488947">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-1089253213488947"><label>1</label>University of Florida, Gainesville, FL, USA</aff>
<author-notes>
<corresp id="corresp1-1089253213488947">Mark Bleiweis, Congenital Heart Center, College of Medicine, University of Florida, 1600 SW Archer Road, HD 314-B, Box 100296, Gainesville, FL 32610-0296, USA. Email: <email>bleiweis@ufl.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>6</month>
<year>2013</year>
</pub-date>
<volume>17</volume>
<issue>2</issue>
<fpage>128</fpage>
<lpage>136</lpage>
<permissions>
<copyright-statement>© The Author(s) 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Hypoplastic left heart syndrome is a congenital heart defect characterized by hypoplasia of left heart structures. Over the past 3 decades, there have been advances in techniques and management in the care of these patients. We discuss shunt selection, operative strategies, transplantation, and outline various facets of management at the University of Florida. This is a review of the literature highlighting some of the technical aspects of the preoperative, operative, and postoperative care that are important in today’s management of hypoplastic left heart syndrome.</p>
</abstract>
<kwd-group>
<kwd>neonate</kwd>
<kwd>cardiac surgery</kwd>
<kwd>cardiopulmonary bypass</kwd>
<kwd>cardiovascular risk factors</kwd>
<kwd>cardiac anesthesia</kwd>
<kwd>children</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1089253213488947">
<title>Introduction</title>
<p>Hypoplastic left heart syndrome (HLHS) is a congenital heart defect in which the left heart is severely underdeveloped. Although the segmental anatomy is normal, the left heart structures are unable to support the systemic circulation. Among the larger diagnosis of congenital heart disease, the incidence depending on the series ranges between 4% and 9%. The first reports of left heart hypoplasia associated with aortic atresia were described by Canton in the 1850s. In the mid-1950s, Lev and Brockman further identified cases of mitral atresia and aortic atresia in conjunction with hypoplasia of the left heart.<sup><xref ref-type="bibr" rid="bibr1-1089253213488947">1</xref>,<xref ref-type="bibr" rid="bibr2-1089253213488947">2</xref></sup> It was not until 1958 when Noonan and Nadas formally coined the phrase “hypoplastic left heart syndrome.”<sup><xref ref-type="bibr" rid="bibr1-1089253213488947">1</xref>,<xref ref-type="bibr" rid="bibr3-1089253213488947">3</xref></sup></p>
<p>Patients with this syndrome present with symptoms of respiratory distress, tachycardia, and cyanosis. Typically, most children die within the first 6 weeks of life secondary to cardiovascular collapse, poor peripheral perfusion, and pulmonary edema. The use of prostaglandin (PGE1) has revolutionized the immediate management of these infants. PGE1 allows for prolonged ductal patency, which facilitates better resuscitation and allows time for a more methodical workup.</p>
</sec>
<sec id="section2-1089253213488947">
<title>Anatomy and Diagnosis</title>
<p>In babies with HLHS or hypoplast variant, the left-sided cardiac structures are partially or completely underdeveloped before birth. The aortic and mitral valves are either too small to allow sufficient blood flow or are simply atretic altogether.<sup><xref ref-type="bibr" rid="bibr4-1089253213488947">4</xref></sup> As blood returns from the lungs to the left atrium, it must pass through an atrial septal defect to the right side of the heart, thus allowing the egress of blood out of the heart to the lungs via the main pulmonary artery and to the body via the patent ductus arteriosus.</p>
<p>The preliminary stages of evaluation involve characterizing the heart in terms of the 4 anatomic subtypes: (<italic>a</italic>) aortic atresia/mitral atresia, (<italic>b</italic>) aortic atresia/mitral stenosis, (<italic>c</italic>) aortic stenosis/mitral stenosis, and (<italic>d</italic>) aortic stenosis/mitral atresia.</p>
<p>Preoperative characteristics have major implication for postoperative outcome. For example, of the anatomic subtypes, mitral stenosis/aortic atresia may be associated with worse outcome. The ascending aorta is frequently 2 mm in diameter from the sinotubular junction to the arch, and coronary perfusion is often compromised with the presence of coronary sinusoids or fistulae. A generalized thickening of the left atrium and pulmonary veins may also further complicate these cases. Oftentimes, prominent endocardial fibroelastosis, scarring of the myocardium and ventriculocoronary communications are part of this subtype.<sup><xref ref-type="bibr" rid="bibr5-1089253213488947">5</xref></sup> It is becoming clear that there are higher risk subsets with lower 5-year survival. This includes those with mitral stenosis/aortic atresia, lower birth weight, additional congenital anomalies, a genetic syndrome, or those with a highly restrictive atrial septum. Even in our modern era of treatment and therapeutic interventions the outcome still remains guarded for these subsets of patients.<sup><xref ref-type="bibr" rid="bibr6-1089253213488947">6</xref><xref ref-type="bibr" rid="bibr7-1089253213488947"/><xref ref-type="bibr" rid="bibr8-1089253213488947"/>-<xref ref-type="bibr" rid="bibr9-1089253213488947">9</xref></sup> The remaining 3 types are varied anatomically but do not seem have a statistically significant difference in terms of survival.</p>
<p>The main diagnostic modality is 2-dimensional transthoracic echocardiography. Prenatal ultrasounds should be highly sensitive and specific for revealing cardiac anomalies, and HLHS is diagnosed prenatally in 28% of affected patients.<sup><xref ref-type="bibr" rid="bibr10-1089253213488947">10</xref>,<xref ref-type="bibr" rid="bibr11-1089253213488947">11</xref></sup> Early diagnosis is critical for parental counseling and to allow preparedness for involved medical personnel. Once the child is born, postnatal imaging will verify the diagnosis and help tailor the acute medical management. Patients diagnosed with HLHS prenatally have lower rate of preoperative acidosis, tricuspid regurgitation, ventricular dysfunction, and better early postoperative survival.<sup><xref ref-type="bibr" rid="bibr12-1089253213488947">12</xref></sup> There is rarely the need for more invasive studies unless the infant has a restrictive atrial septum requiring an urgent balloon septostomy in the catheterization lab for optimal left atrial decompression.<sup><xref ref-type="bibr" rid="bibr8-1089253213488947">8</xref></sup></p>
</sec>
<sec id="section3-1089253213488947">
<title>Preoperative Management</title>
<p>The importance of preoperative management cannot be overstated—it is essential to patient survival. If the diagnosis is not suspected on fetal ultrasound, the cardiovascular anomaly must first be recognized and the child transferred to a tertiary care center with specialization in congenital heart disease.<sup><xref ref-type="bibr" rid="bibr13-1089253213488947">13</xref></sup> Resuscitative and supportive therapies include PGE1, ventilatory support, and inotropic and other vasoactive agents. The goal is to achieve a balanced pulmonary (Qp) and systemic circulation (Qs). Every effort should be made to establish and maintain a balanced Qp:Qs while resuscitation continues.<sup><xref ref-type="bibr" rid="bibr14-1089253213488947">14</xref></sup> Acidosis or an increase in PaCO<sub>2</sub> will cause pulmonary vasoconstriction (decrease Qp), whereas alkalosis or increases in the FiO<sub>2</sub> will cause pulmonary vasodilation (increase in Qp). In limited circumstances, intubation may be necessary. Stieh et al<sup><xref ref-type="bibr" rid="bibr14-1089253213488947">14</xref></sup> demonstrated that in-hospital survival decreases significantly with intubation at any time before surgery. Nevertheless, ventilator support and controlled hypoventilation can be important resuscitative measures in the critically ill or significantly overcirculated HLHS child. Inotropes are often used to augment cardiac output; however, this must be done with caution. These agents also have a tendency to increase systemic vascular resistance, which may acutely change the Qp:Qs ratio with more of the cardiac output now being shunted to the pulmonary circulation leading to congestion, reduced peripheral perfusion, and acidosis.</p>
<p>The optimal timing of surgery is usually within the first week of life. This allows adequate time for medical management, resuscitation, and stabilization. As pulmonary vascular resistance drops shortly after birth, the balance of Qp:Qs will constantly need to be evaluated. Serial echocardiographic studies are performed confirming the diagnosis, and repeat evaluations of blood flow across the atrial septum are conducted. A restrictive atrial septum will cause pulmonary venous congestion. With the severely restricted or intact atrial septum, cardiovascular collapse will ensue. Although a poor prognostic indicator for long-term survival, prompt intervention in the catheterization lab to open the atrial septum should be undertaken.<sup><xref ref-type="bibr" rid="bibr8-1089253213488947">8</xref></sup></p>
</sec>
<sec id="section4-1089253213488947">
<title>Surgical Management and Overview</title>
<p>Historically, most patients with HLHS had a dismal outcome. Dr Norwood described and popularized stage 1 palliation in the mid-1980s. Currently, the surgical procedure has been refined and the outcomes have improved; the tenets of the procedure remain unchanged. These include ascending/arch reconstruction, a nonrestrictive atrial septal defect, a single right ventricle as the systemic ventricle, and a reliable source of pulmonary blood flow via a subclavian artery (Blalock–Taussig [BT] shunt—classic Norwood), polytetrafluoroethylene (PTFE) graft from the subclavian to the right pulmonary artery (modified Norwood), or PTFE graft from the right ventricle to the pulmonary artery (RV to PA; Norwood–Sano).<sup><xref ref-type="bibr" rid="bibr15-1089253213488947">15</xref><xref ref-type="bibr" rid="bibr16-1089253213488947"/>-<xref ref-type="bibr" rid="bibr17-1089253213488947">17</xref></sup></p>
<p>The objectives of the first-stage reconstructive procedure for HLHS involve preservation of ventricular function by excellent myocardial protection during the case and by avoiding a residual pressure gradient after completion of the arch reconstruction.</p>
<p>Another important consideration is the size of the shunt. If inappropriately sized, there may be too little or too much pulmonary blood flow. Ohye et al<sup><xref ref-type="bibr" rid="bibr18-1089253213488947">18</xref></sup> have shown a 12-month survival advantage when RV-to-PA artery conduit was used over modified BT shunt. In our practice, we create a Gore-Tex RV-to-PA conduit (with a homograft patch extension) curving in to the left chest to avoid sternal compression at the time of chest closure.<sup><xref ref-type="bibr" rid="bibr19-1089253213488947">19</xref></sup> In patients weighing less than approximately 2 kg, a 4-mm shunt is used; otherwise, a 5-mm graft is used.</p>
<p>Currently, infants undergo the staged reconstructive surgery (Norwood procedure) within a week after birth, bidirectional Glenn (superior cavopulmonary) shunt at 3 to 6 months of age, and an extracardiac conduit Fontan procedure at 2 to 4 years of age.</p>
</sec>
<sec id="section5-1089253213488947">
<title>Operation With Continuous Perfusion: Stage 1 Palliation</title>
<p>These patients are very brittle and diligent communication between the anesthesia and surgical teams is crucial before and during the procedure. Even slight aberrations in ventilation or inotropic manipulations may substantially alter systemic or pulmonary blood flow and increase early morbidity and/or mortality for this procedure.</p>
<p>Typically, the child is transported to the operating room on room air ventilation or low inspired FiO<sub>2</sub>, and we maintain normocarbia or slight hypercarbia. It is our practice that all ventilation during transport be conducted on a ventilator to minimize any potential hypoventilation or hyperventilation that may not be well tolerated in patients with single ventricle physiology. Standard monitors are used in addition to a right radial arterial line. This is important in order to monitor perfusion pressures throughout the surgical repair as the aorta will be clamped distally to this vessel rendering all other sites of arterial monitoring non-functional. The use of central venous access is not absolutely necessary, as common atrial catheters can be placed during the procedure. Many centers also use near-infrared spectroscopy monitoring of cerebral oxygen saturations. Anesthetic induction should be performed by a pediatric cardiovascular Anesthesiologist with expertise in infants with complex congenital heart disease.</p>
<p>The operating room is cooled to help facilitate even cooling during the procedure. Prior to making the chest incision, the 5-mm Sano Gore-Tex tube graft is extended with a 0.5-cm cuff of homograft tissue. The cuff of homograft tissue will ultimately be sutured to the open bifurcation of the pulmonary artery.</p>
<p>A median sternotomy is made and the heart is accessed after complete or partial resection of the thymus gland for optimum exposure. The arch vessels are dissected to enhance arch mobilization. Some centers perform this procedure with circulatory arrest with good results. There is growing concern about the effects of hypothermic circulatory arrest on the body and brain.<sup><xref ref-type="bibr" rid="bibr16-1089253213488947">16</xref>,<xref ref-type="bibr" rid="bibr20-1089253213488947">20</xref><xref ref-type="bibr" rid="bibr21-1089253213488947"/>-<xref ref-type="bibr" rid="bibr22-1089253213488947">22</xref></sup> Moderate to deep hypothermia with selective cerebral perfusion is an accepted perfusion strategy for arch reconstruction.<sup><xref ref-type="bibr" rid="bibr20-1089253213488947">20</xref>,<xref ref-type="bibr" rid="bibr23-1089253213488947">23</xref></sup> It is our preference to use continuous, regional cerebral perfusion via the innominate artery during arch augmentation thereby avoiding deep hypothermic circulatory arrest completely.<sup><xref ref-type="bibr" rid="bibr24-1089253213488947">24</xref>,<xref ref-type="bibr" rid="bibr25-1089253213488947">25</xref></sup> Following heparinization, arterial cannulation is via a 6- or 8-Fr. cannula in the innominate artery and an 8-Fr arterial cannula in the ductus. A single venous cannula, usually a 16-Fr cannula, is placed in the right atrial appendage (<xref ref-type="fig" rid="fig1-1089253213488947">Figure 1</xref>).</p>
<fig id="fig1-1089253213488947" position="float">
<label>Figure 1.</label>
<caption>
<p>Hypoplastic left heart syndrome cannulation strategy: Innominate arterial and superior vena cava venous cannulation.</p>
</caption>
<graphic xlink:href="10.1177_1089253213488947-fig1.tif"/>
</fig>
<p>Immediately after beginning bypass a ligature is snared around the proximal ductus with care to avoid distortion of the takeoffs of the right and left pulmonary artery. This prevents excessive run off to the pulmonary circulation and allows more even perfusion and cooling. The patient is cooled to 18°C to 22°C and perfusion flow is decreased as appropriate for the reduced temperature. We have routinely used phentolamine to cause vasodilation to ensure effective and even cooling. The proximal main pulmonary artery is divided 2 to 3 mm above the tops of the commissures of the pulmonary valve. The distal anastomosis of the RV-to-PA shunt to the pulmonary artery is now performed. For the neonate weighing more than 2.0 kg, a 5-mm stretch PTFE tube graft should be selected (<xref ref-type="fig" rid="fig2-1089253213488947">Figures 2</xref> and <xref ref-type="fig" rid="fig3-1089253213488947">3</xref>).</p>
<fig id="fig2-1089253213488947" position="float">
<label>Figure 2.</label>
<caption>
<p>Dissected anatomy prior to modified Norwood procedure: Ductus ligation and division, pulmonary artery transection. Underside of the hypoplastic arch is fillet open.</p>
</caption>
<graphic xlink:href="10.1177_1089253213488947-fig2.tif"/>
</fig>
<fig id="fig3-1089253213488947" position="float">
<label>Figure 3.</label>
<caption>
<p>Distal Sano anastomosis: 5-mm Gore-Tex graft sutured to pulmonary artery in end to side fashion.</p>
</caption>
<graphic xlink:href="10.1177_1089253213488947-fig3.tif"/>
</fig>
<p>After completion of the main pulmonary artery anastomosis, a complete atrial septectomy is performed, which allows for full systemic and pulmonary venous mixing postoperatively. Furthermore, as the infant grows, any chance of developing a restrictive atrial septum is minimized. The atrial septectomy can be performed rapidly with the venous cannula clamped and pump suckers in the atrium to allow for adequate drainage and visualization.</p>
<p>The ductal cannula is then removed and the ductus is ligated and divided. The distal arch and descending aorta is fully dissected and mobilized. The cross clamp is applied to the proximal arch and a neuro clip is applied to the distal innominate artery. Cold antegrade cardioplegia is administered to the root via the innominate cannula to fully arrest and protect the heart.</p>
<p>It is our practice to use homograft although others have reported good results with autologous pericardium.<sup><xref ref-type="bibr" rid="bibr26-1089253213488947">26</xref></sup> Once the homograft has thawed, it should be trimmed for the arch reconstruction according to the length and diameter of the arch. The cross clamp is now moved to the base of the innominate and regional low-flow cerebral perfusion is now started. The left carotid and left subclavian are now snared. The underside of the arch is filleted open. Remnants of ductal tissue are excised from the descending thoracic aorta. We feel that this is important to prevent late neoaortic stenosis. Proximally, the arch and ascending aorta are filleted open to the level of the division of the main pulmonary artery. This is extended well past the area of the ductus on to the descending aorta. The entire arch is now augmented with a generous patch of pulmonary homograft and an anastomosis is constructed between opened, hypoplastic proximal aorta, the transected proximal pulmonary artery, hypoplastic ascending aorta, and tailored homograft down to the level of the divided pulmonary artery. It is important that the neoaorta not be redundant, so as to not create a bowstring effect over the left pulmonary artery, which can be compressed between the neoaorta and the left main bronchus. Furthermore, attempts to do the repair without some tissue (either autologous pericardium or homograft) may lead to pulmonary artery stenosis or left bronchial compression.<sup><xref ref-type="bibr" rid="bibr27-1089253213488947">27</xref></sup></p>
<p>Careful consideration must be given to the distensibility of the homograft tissue and to the contribution to the neoaorta by the original ascending aorta. An excessively large proximal neoaorta will compress the reconstructed pulmonary artery bifurcation, resulting in a central stenosis.</p>
</sec>
<sec id="section6-1089253213488947">
<title>Pitfalls</title>
<p>Although there are many steps of this operation, much hinges on size and patency of the anastomosis to the hypoplastic, ascending aorta. There must be very little twist or torque to the anastomosis or coronary hypoperfusion can result and the outcome could prove devastating. Marking sutures can help with the orientation, although we have not found them necessary for a successful operation. What is necessary is the precise approximation of the neoaorta and the small, native ascending aorta with 3 to 4 simple interrupted stitches (<xref ref-type="fig" rid="fig4-1089253213488947">Figure 4A</xref> and <xref ref-type="fig" rid="fig4-1089253213488947">B</xref>). As noted above, the careful patch augmentation of the hypoplastic arch is crucial for long-term freedom from catheter-based interventions.<sup><xref ref-type="bibr" rid="bibr2-1089253213488947">2</xref></sup></p>
<fig id="fig4-1089253213488947" position="float">
<label>Figure 4.</label>
<caption>
<p>(A) Proximal neoaorta: Precise placement of sutures between the hypoplastic ascending and neoaortic/pulmonary valve. (B). Arch reconstruction: Completion of neoaortic arch with homograft patch.</p>
</caption>
<graphic xlink:href="10.1177_1089253213488947-fig4.tif"/>
</fig>
</sec>
<sec id="section7-1089253213488947">
<title>Shunts</title>
<p>Although some centers may perform the classic Norwood or the modified Norwood operation, it is our preference to perform the Norwood with Sano modification, or RV-to-PA conduit. There is a general consensus that the initial postoperative course is more stable. An important difference is that the RV-to-PA conduit leads to a higher diastolic pressure, and because there is no direct competition for coronary blood flow, there is less coronary steal and less coronary hypoperfusion.<sup><xref ref-type="bibr" rid="bibr19-1089253213488947">19</xref>,<xref ref-type="bibr" rid="bibr28-1089253213488947">28</xref></sup> The usual shunt is 5 mm in length that curves into the left chest to avoid any unwanted bending or sternal compression (<xref ref-type="fig" rid="fig5-1089253213488947">Figure 5</xref>).<sup><xref ref-type="bibr" rid="bibr19-1089253213488947">19</xref></sup> Once the Sano shunt anastomosis is completed and rewarming has occurred, the patient can we weaned slowly from circulatory support.</p>
<fig id="fig5-1089253213488947" position="float">
<label>Figure 5.</label>
<caption>
<p>Proximal Sano anastomosis: After arch reconstruction, 5-mm Sano is anastomosed to the right ventriculotomy.</p>
</caption>
<graphic xlink:href="10.1177_1089253213488947-fig5.tif"/>
</fig>
</sec>
<sec id="section8-1089253213488947">
<title>Weaning From Bypass</title>
<p>We routinely place a double lumen common atrial line for administration of inotropes and vasodilators and for filling pressure monitoring. We prefer epinephrine and milrinone for inotropic support, and these infusions are titrated depending on the intraoperative assessment of contractility (usually transesophageal echocardiography). Nitroprusside is used to rapidly address increases in ventricular afterload. The heart can be irritable during the period around separation from bypass and attention to the rhythm is critical. Atrial and ventricular epicardial leads are placed and pacing at approximately 150 beats per minute, if necessary, can be instituted for bradycardia or junctional rhythms.</p>
<p>During the weaning from support, we prefer the patient to be slightly alkalotic. Hyperventilation and judicious use of sodium bicarbonate can typically fix the aberrations in pH. An upper and lower extremity pulse oximeter is an important indicator of perfusion and oxygenation. The target saturations should be in the mid-70s to the mid-80s. There is often a period of time when the saturations are low just after coming off bypass and will gradually improve. Although overcirculation is a general concern even with an RV-to-PA conduit, one must resist the temptation to aggressively wean the oxygen post bypass if the saturations are in the 90s and the systemic blood pressure is adequate. The gentle weaning of the oxygen can be done in the intensive care unit over a longer period of time.</p>
</sec>
<sec id="section9-1089253213488947">
<title>Postoperative Period</title>
<p>The initial priority in the early postoperative course is to achieve hemodynamic stability. For this reason, we routinely leave the chest open for planned delayed sternal closure in 2 to 5 days.<sup><xref ref-type="bibr" rid="bibr29-1089253213488947">29</xref></sup> Although there are some data that associates worse outcomes with delayed sternal closure,<sup><xref ref-type="bibr" rid="bibr9-1089253213488947">9</xref></sup> we have not seen this particular trend at our institutions. It is our feeling that management of HLHS with delayed sternal closure more readily accommodates for chest wall and abdominal swelling as well as pericardial and pleural fluid accumulation, and it facilitates gradual improvement in pulmonary compliance. After achieving and maintaining hemodynamic stability, early aggressive diuresis is used to reduce tissue edema, which will result in improved cardiac and pulmonary compliance and function. We initiate and titrate furosemide infusions at 0.1 to 0.4 mg/kg/h to achieve an effective diuresis without the profound intravascular volume shifts seen with bolus dosing.</p>
<p>Once the chest wall edema dissipates, the sternum is closed in the pediatric intensive care unit, and weaning to extubation usually occurs over a 1- to 3-day period after sternal reapproximation. Inotropes, inodilators, and vasodilators are weaned as tolerated. Although nutritional support is instituted within the first few days post–Norwood procedure, resuming oral feeding may be delayed because of numerous factors, such as vocal cord paresis, pharyngoesophageal or gastrointestinal dysmotility, and neurologic conditions. In our experience, feeding issues are the major factor delaying most hospital discharges.</p>
<p>Ohye et al<sup><xref ref-type="bibr" rid="bibr30-1089253213488947">30</xref></sup> note that death often is associated with a prodrome of gut-related issues. Many of these neonates are prone to gastrointestinal complications such as necrotizing enterocolitis, prolonged feeding, and need for long-term feeding access. All patients with HLHS in our institution get a formal speech/swallow evaluation and the feeding regimen will be tailored accordingly.<sup><xref ref-type="bibr" rid="bibr13-1089253213488947">13</xref>,<xref ref-type="bibr" rid="bibr31-1089253213488947">31</xref><xref ref-type="bibr" rid="bibr32-1089253213488947"/><xref ref-type="bibr" rid="bibr33-1089253213488947"/>-<xref ref-type="bibr" rid="bibr34-1089253213488947">34</xref></sup> Jefferies et al<sup><xref ref-type="bibr" rid="bibr34-1089253213488947">34</xref></sup> report a need for gastrostomy tube placement in approximately 18%. Once chest closure has occurred, and swallowing has been formally evaluated, parenteral/enteral nutrition is maximized.</p>
<p>The ultimate goal of the initial palliative operation and all other staging procedures is to maintain anatomic and physiologic substrate amenable to successful Fontan completion. Until that time, management of single ventricle physiology and balancing systemic and pulmonary circulation will predominate the child’s development. Patients at low risk for progress to complete Fontan circulation (total cavopulmonary connection) require preservation of systolic and diastolic function, an adequate atrioventricular valve, a widely patent atrial communication and unobstructed pulmonary veins, adequate pulmonary arteries, and unobstructed aortic outflow. These children need frequent clinical evaluations and close monitoring. Within a few months these patients may outgrow their RV-to-PA conduit or modified BT shunt and the saturations will gradually decrease (70% to 75%). It is important at that point in time (3-6 months) that they undergo cardiac catheterization to evaluate candidacy for stage 2—bidirectional Glenn. Some institutions may proceed to bidirectional Glenn stage on the basis of cardiac magnetic resonance imaging in the absence of hemodynamic data.<sup><xref ref-type="bibr" rid="bibr35-1089253213488947">35</xref></sup> The catheter-based or magnetic resonance images provide a detailed road map of the cardiac anatomy. In particular, the arch and/or the pulmonary arteries may be kinked or narrowed as the child grows. These areas may need revision at the time of the bidirectional glen or may need preoperative angioplasty.</p>
<p>The transthoracic or transesophageal echoes also are critical in the decision making. It is not uncommon that the atrioventricular valve becomes regurgitant. This valve may need to be addressed at the time of the second-stage procedure or may prove to be prohibitive for future Fontan completion, rendering the patient a transplant candidate. AV valve regurgitation is an independent risk factor for death or transplantation.<sup><xref ref-type="bibr" rid="bibr36-1089253213488947">36</xref></sup> Elmi et al<sup><xref ref-type="bibr" rid="bibr37-1089253213488947">37</xref></sup> demonstrated that a majority of patients have hemodynamically significant tricuspid regurgitation after Norwood procedure. Many of these patients may have this addressed during subsequent operations in the form of a posterior annuloplasty.<sup><xref ref-type="bibr" rid="bibr37-1089253213488947">37</xref>,<xref ref-type="bibr" rid="bibr38-1089253213488947">38</xref></sup></p>
</sec>
<sec id="section10-1089253213488947">
<title>Stage 2: Bidirectional Glenn Procedure</title>
<p>During the second-stage palliation, the bidirectional cavopulmonary connection or bidirectional Glenn shunt, the superior vena cava is separated from the heart and connected to the pulmonary circulation (<xref ref-type="fig" rid="fig6-1089253213488947">Figure 6</xref>). The systemic to pulmonary artery or RV-to-PA shunt is disconnected and the lungs are no longer exposed to systemic arterial pressures but rather lower central venous pressure. The bidirectional Glenn procedure unloads the single ventricle and cardiac function often improves. The patient will still remain desaturated as deoxygenated blood from the lower extremities still circulates through the heart mixing with oxygenated blood in the left atrium.</p>
<fig id="fig6-1089253213488947" position="float">
<label>Figure 6.</label>
<caption>
<p>Bidirectional Glenn procedure: The superior vena cava is amputated from the right atrium and an end to side anastomosis is made between the superior vena cava and pulmonary artery.</p>
</caption>
<graphic xlink:href="10.1177_1089253213488947-fig6.tif"/>
</fig>
</sec>
<sec id="section11-1089253213488947">
<title>Stage 3: Modified Fontan Procedure</title>
<p>Patients undergo cardiac catheterization for preoperative hemodynamic and anatomic evaluation. Preoperative echocardiography evaluates cardiac function and the competency of the atrioventricular valve. The modified Fontan operation completes the series of repairs for those diagnosed with HLHS. This was originally described by Fontan in 1971 and has been modified to a lateral tunnel or an extracardiac conduit.<sup><xref ref-type="bibr" rid="bibr39-1089253213488947">39</xref><xref ref-type="bibr" rid="bibr40-1089253213488947"/>-<xref ref-type="bibr" rid="bibr41-1089253213488947">41</xref></sup> The functional effect is to redirect venous blood from the lower body (through the inferior vena cava) away from the right atrium to the pulmonary artery. There no longer is any mixing of oxygenated and deoxygenated blood in the right ventricle. The right ventricle performs the traditional job of the left, supplying the body with oxygenated blood. The relatively low pressures in the pulmonary circulation allows for the passive flow of venous deoxygenated blood to the lungs.</p>
<p>There are 2 basic types of modified Fontan. The lateral tunnel Fontan procedure provides an intra-atrial route directing blood from the inferior vena cava to the pulmonary arteries and requires aortic cross clamping and cardiac arrest. At the University of Florida, we exclusively perform the extracardiac conduit procedure using a Gore-Tex extracardiac tube graft (usually 16-20 mm in diameter) to connect the inferior vena cava to the pulmonary arteries. We feel this technique reduces the long-term complications associated with the other types of modified Fontan procedures, such as atrial clot formation, atrial arrhythmias, and left atrial dilation (<xref ref-type="fig" rid="fig7-1089253213488947">Figure 7</xref>).<sup><xref ref-type="bibr" rid="bibr42-1089253213488947">42</xref></sup></p>
<fig id="fig7-1089253213488947" position="float">
<label>Figure 7.</label>
<caption>
<p>Modified extracardiac Fontan: Extracardiac Gore-Tex graft is used to provide flow from the inferior vena cava to the pulmonary artery.</p>
</caption>
<graphic xlink:href="10.1177_1089253213488947-fig7.tif"/></fig>
<p>Fontan fenestration, a communication between the Fontan circuit and the common atrium, can improve systemic ventricular filling—at the expense of oxygen saturation—to ensure systemic output. Although some programs use routine fenestration to avoid early postoperative low output state and for a theoretical reduction in perioperative pleural effusions, we use selective fenestration in high-risk patients only. Rarely, nonfenestrated patients can be returned to the operating room if there are postoperative factors contributing to a low cardiac output state. For example, if the Fontan pressure is high (&gt;15-20) with low common atrial and systemic pressures and pulmonary resistance problems are not easily and rapidly reversible, fenestration is necessary.</p>
</sec>
<sec id="section12-1089253213488947">
<title>Hybrid Approach</title>
<p>Although there have been many advances in the surgical management of HLHS, morbidity and mortality are still substantial when compared with other surgical procedures. This has prompted alternative efforts to successfully manage this disease process. The hybrid approach is a collaborative attempt between interventional cardiologists and congenital surgeons to jointly address the reduction of pulmonary flow via surgical pulmonary artery banding and stent deployment in the patent ductus arteriosus—thereby establishing reliable systemic perfusion.<sup><xref ref-type="bibr" rid="bibr28-1089253213488947">28</xref>,<xref ref-type="bibr" rid="bibr43-1089253213488947">43</xref></sup> This approach performed via sternotomy in a hybrid operating / interventional radiology suite allows for real-time images and hemodynamics.<sup><xref ref-type="bibr" rid="bibr44-1089253213488947">44</xref></sup> This procedure potentially decreases the adverse effects of cardiopulmonary bypass in stage 1 palliation; however, this potential risk reduction in the first stage is shifted to stage 2 palliation, which now becomes more complicated. The second stage is conducted at 4 to 6 months and consists of stent removal, aortic arch reconstruction, pulmonary artery reconstruction, and bidirectional cavopulmonary anastomosis superimposed on a redo-sternotomy.<sup><xref ref-type="bibr" rid="bibr28-1089253213488947">28</xref>,<xref ref-type="bibr" rid="bibr45-1089253213488947">45</xref>,<xref ref-type="bibr" rid="bibr46-1089253213488947">46</xref></sup> Centers committed to this approach achieve results comparable to the conventional Norwood approach.</p>
</sec>
<sec id="section13-1089253213488947">
<title>Outcomes</title>
<p>When dealing with HLHS, a successful outcome depends on a multidisciplinary approach to all phases of care. Even after all 3 stages, patients with HLHS will require lifelong follow-up by a pediatric cardiologist. Currently, the operative survival ranges between 75% and 95%. At the University of Florida, the most current short-term survival data harvest reflects a 90% survival from the January 2007 to January 2013. Short-term survival (1-year) approaches 75% with medium- and long-term survival (10 years) approaching 50% to 60%.<sup><xref ref-type="bibr" rid="bibr3-1089253213488947">3</xref></sup> The major losses during this time period often come between the first and second operations or as a result of progressive heart failure. Interstage mortality can account for 4% to 16% resulting from right ventricular dysfunction, arrhythmias, and obstruction at the pulmonary or neoaortic arch.<sup><xref ref-type="bibr" rid="bibr7-1089253213488947">7</xref>,<xref ref-type="bibr" rid="bibr47-1089253213488947">47</xref></sup> Many congenital programs have implemented home monitoring systems with hopes to lessen interstage mortality.<sup><xref ref-type="bibr" rid="bibr7-1089253213488947">7</xref>,<xref ref-type="bibr" rid="bibr30-1089253213488947">30</xref></sup> Patients are discharged with oxygen saturation monitoring and a scale to monitor adequate weight gain. Parents are given clear instruction and parameters that should trigger early evaluation to avoid potential crises. Long-term complications include gradual worsening of cardiac function, protein-losing enteropathy, worsening atrioventricular valve regurgitation, and plastic bronchitis. Many of these patients eventually require intensive heart failure management and heart transplantation.<sup><xref ref-type="bibr" rid="bibr48-1089253213488947">48</xref></sup> Unfortunately, 25% to 35% of these patients waiting for organs will expire during this period.<sup><xref ref-type="bibr" rid="bibr28-1089253213488947">28</xref>,<xref ref-type="bibr" rid="bibr49-1089253213488947">49</xref>,<xref ref-type="bibr" rid="bibr50-1089253213488947">50</xref></sup> Those that do undergo cardiac transplantation have a 5-year survival of approximately 50% to 60% as a group.</p>
<p>The role of ventricular assist devices in these patients is in its infancy and may play a greater role as we better understand how to manage ventricular assist devices in single ventricular physiology.</p>
</sec>
<sec id="section14-1089253213488947">
<title>Conclusion</title>
<p>Hypoplastic left heart syndrome requires a staged approach to achieve palliation to Fontan circulation. In our experience, the Norwood modification using an RV-to-PA conduit results in stable postoperative hemodynamics and improved survival. A multidisciplinary approach is required to ensure excellence in preoperative and postoperative care. Transplantation is still required for a significant number of patients at all stages of palliation. The role of ventricular assist devices for the patient with HLHS and heart failure is unknown.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<label>Declaration of Conflicting Interests</label>
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>The author(s) received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1089253213488947">
<label>1.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Kouchoukos</surname><given-names>NT</given-names></name>
<name><surname>Blackstone</surname><given-names>EH</given-names></name>
<name><surname>Hanley</surname><given-names>FL</given-names></name>
<name><surname>Kirklin</surname><given-names>JK</given-names></name>
</person-group>. <article-title>Aortic atresia and other forms of hypoplastic left heart physiology</article-title>. In: <source>Cardiac Surgery vol. 2</source>. <edition>4th ed.</edition> <publisher-loc>Philadelphia, PA</publisher-loc>: <publisher-name>Elsevier Saunders</publisher-name>; <year>2013</year>:<fpage>1780</fpage>-<lpage>1812</lpage>.</citation>
</ref>
<ref id="bibr2-1089253213488947">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sakurai</surname><given-names>T</given-names></name>
<name><surname>Rogers</surname><given-names>V</given-names></name>
<name><surname>Stickley</surname><given-names>J</given-names></name><etal/>
</person-group>. <article-title>Single-center experience of arch reconstruction in the setting of Norwood operation</article-title>. <source>Ann Thorac Surg</source>. <year>2012</year>;<volume>94</volume>:<fpage>1534</fpage>-<lpage>1539</lpage>.</citation>
</ref>
<ref id="bibr3-1089253213488947">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Noonan</surname><given-names>JA</given-names></name>
<name><surname>Nadas</surname><given-names>AS</given-names></name>
</person-group>. <article-title>The hypoplastic left heart syndrome: an analysis of 101 cases</article-title>. <source>Pediatr Clin North Am</source>. <year>1958</year>;<volume>5</volume>:<fpage>1029</fpage>-<lpage>1056</lpage>.</citation>
</ref>
<ref id="bibr4-1089253213488947">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Emani</surname><given-names>SM</given-names></name>
<name><surname>McElhinney</surname><given-names>DB</given-names></name>
<name><surname>Tworetzky</surname><given-names>W</given-names></name><etal/>
</person-group>. <article-title>Staged left ventricular recruitment after single-ventricle palliation in patient with borderline left heart hypoplasia</article-title>. <source>J Am Coll Cardiol</source>. <year>2012</year>;<volume>60</volume>:<fpage>1966</fpage>-<lpage>1974</lpage>.</citation>
</ref>
<ref id="bibr5-1089253213488947">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sugiyama</surname><given-names>H</given-names></name>
<name><surname>Yutani</surname><given-names>C</given-names></name>
<name><surname>Iida</surname><given-names>K</given-names></name>
<name><surname>Arakaki</surname><given-names>Y</given-names></name>
<name><surname>Yamada</surname><given-names>O</given-names></name>
<name><surname>Kamiya</surname><given-names>T</given-names></name>
</person-group>. <article-title>The relation between right ventricular function and left ventricular morphology in hypoplastic left heart syndrome: angiographic and pathological studies</article-title>. <source>Pediatr Cardiol</source>. <year>1999</year>;<volume>20</volume>:<fpage>422</fpage>-<lpage>427</lpage>.</citation>
</ref>
<ref id="bibr6-1089253213488947">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vlahos</surname><given-names>AP</given-names></name>
<name><surname>Lock</surname><given-names>JE</given-names></name>
<name><surname>McElhinney</surname><given-names>DB</given-names></name>
<name><surname>van der velde</surname><given-names>ME</given-names></name>
</person-group>. <article-title>Hypoplastic left heart syndrome with intact or highly restrictive atrial septum: outcome after neonatal transcatheter atrial septostomy</article-title>. <source>Circulation</source>. <year>2004</year>;<volume>109</volume>:<fpage>2326</fpage>-<lpage>2330</lpage>.</citation>
</ref>
<ref id="bibr7-1089253213488947">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Glatz</surname><given-names>JA</given-names></name>
<name><surname>Fedderly</surname><given-names>RT</given-names></name>
<name><surname>Ghanayem</surname><given-names>NS</given-names></name>
<name><surname>Tweddell</surname><given-names>JS</given-names></name>
</person-group>. <article-title>Impact of mitral stenosis and aortic atresia on survival in hypoplastic left heart syndrome</article-title>. <source>Ann Thorac Surg</source>. <year>2008</year>;<volume>85</volume>:<fpage>2057</fpage>-<lpage>2062</lpage>.</citation>
</ref>
<ref id="bibr8-1089253213488947">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Glatz</surname><given-names>JA</given-names></name>
<name><surname>Tabbutt</surname><given-names>S</given-names></name>
<name><surname>Gaynor</surname><given-names>JW</given-names></name><etal/>
</person-group>. <article-title>Hypoplastic left heart syndrome with atrial level restriction in the era of prenatal diagnosis</article-title>. <source>Ann Thorac Surg</source>. <year>2007</year>;<volume>84</volume>:<fpage>1633</fpage>-<lpage>1639</lpage>.</citation>
</ref>
<ref id="bibr9-1089253213488947">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tabbutt</surname><given-names>S</given-names></name>
<name><surname>Ghanayem</surname><given-names>N</given-names></name>
<name><surname>Ravishankar</surname><given-names>C</given-names></name><etal/>
</person-group>; <collab>Pediatric Heart Network Investigators</collab>. <article-title>Risk factors for hospital morbidity and mortality after the Norwood procedure: a report from the Pediatric Heart Network Single Ventricle Reconstruction Trial</article-title>. <source>J Thorac Cardiovasc Surg</source>. <year>2012</year>;<volume>144</volume>:<fpage>882</fpage>-<lpage>895</lpage>.</citation>
</ref>
<ref id="bibr10-1089253213488947">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Montana</surname><given-names>E</given-names></name>
<name><surname>Khoury</surname><given-names>MJ</given-names></name>
<name><surname>Cragan</surname><given-names>JD</given-names></name>
<name><surname>Sharma</surname><given-names>S</given-names></name>
<name><surname>Dhar</surname><given-names>P</given-names></name>
<name><surname>Fyfe</surname><given-names>D</given-names></name>
</person-group>. <article-title>Trends and outcomes after prenatal diagnosis of congenital cardiac malformations by fetal echocardiography in a well-defined birth population, Atlanta, Georgia, 1990-1994</article-title>. <source>J Am Coll Cardiol</source>. <year>1996</year>;<volume>28</volume>:<fpage>1805</fpage>-<lpage>1809</lpage>.</citation>
</ref>
<ref id="bibr11-1089253213488947">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Blake</surname><given-names>DM</given-names></name>
<name><surname>Copel</surname><given-names>JA</given-names></name>
<name><surname>Kleinman</surname><given-names>CS</given-names></name>
</person-group>. <article-title>Hypoplastic left heart syndrome: prenatal diagnosis, clinical profile, and management</article-title>. <source>Am J Obstet Gynecol</source>. <year>1991</year>;<volume>165</volume>:<fpage>529</fpage>-<lpage>534</lpage>.</citation>
</ref>
<ref id="bibr12-1089253213488947">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tworetzky</surname><given-names>W</given-names></name>
<name><surname>McElhinney</surname><given-names>DB</given-names></name>
<name><surname>Reddy</surname><given-names>VM</given-names></name>
<name><surname>Brook</surname><given-names>MM</given-names></name>
<name><surname>Hanley</surname><given-names>FL</given-names></name>
<name><surname>Silverman</surname><given-names>NH</given-names></name>
</person-group>. <article-title>Improved surgical outcome after fetal diagnosis of hypoplastic left heart syndrome</article-title>. <source>Circulation</source>. <year>2001</year>;<volume>103</volume>:<fpage>1269</fpage>-<lpage>1273</lpage>.</citation>
</ref>
<ref id="bibr13-1089253213488947">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Berry</surname><given-names>JG</given-names></name>
<name><surname>Cowley</surname><given-names>CG</given-names></name>
<name><surname>Hoff</surname><given-names>CJ</given-names></name>
<name><surname>Srivastava</surname><given-names>R</given-names></name>
</person-group>. <article-title>In-hospital mortality for children with hypoplastic left heart syndrome after stage 1 surgical palliation: teaching versus nonteaching hospitals</article-title>. <source>Pediatrics</source>. <year>2006</year>;<volume>117</volume>:<fpage>1307</fpage>-<lpage>1313</lpage>.</citation>
</ref>
<ref id="bibr14-1089253213488947">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stieh</surname><given-names>J</given-names></name>
<name><surname>Fischer</surname><given-names>G</given-names></name>
<name><surname>Scheewe</surname><given-names>J</given-names></name><etal/>
</person-group>. <article-title>Impact of preoperative treatment strategies on the early perioperative outcome in neonates with hypoplastic left heart syndrome</article-title>. <source>J Thorac Cardiovasc Surg</source>. <year>2006</year>;<volume>131</volume>:<fpage>1122.e2</fpage>-<lpage>1129.e2</lpage>.</citation>
</ref>
<ref id="bibr15-1089253213488947">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Poirier</surname><given-names>NC</given-names></name>
<name><surname>Drumond-Webb</surname><given-names>JJ</given-names></name>
<name><surname>Hisamochi</surname><given-names>K</given-names></name>
<name><surname>Imamura</surname><given-names>M</given-names></name>
<name><surname>Harrison</surname><given-names>AM</given-names></name>
<name><surname>Mee</surname><given-names>R</given-names></name>
</person-group>. <article-title>Modified Norwood procedure with a high flow cardiopulmonary bypass strategy results in low mortality without late arch obstruction</article-title>. <source>J Thorac Cardiovasc Surg</source>. <year>2000</year>;<volume>120</volume>:<fpage>875</fpage>-<lpage>884</lpage>.</citation>
</ref>
<ref id="bibr16-1089253213488947">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Burkhart</surname><given-names>HM</given-names></name>
<name><surname>Ashburn</surname><given-names>DA</given-names></name>
<name><surname>Konstantinov</surname><given-names>IE</given-names></name><etal/>
</person-group>. <article-title>Interdigitating arch reconstruction eliminates recurrent coarctation after the Norwood procedure</article-title>. <source>J Thorac Cardiovasc Surg</source>. <year>2005</year>;<volume>130</volume>:<fpage>61</fpage>-<lpage>65</lpage>.</citation>
</ref>
<ref id="bibr17-1089253213488947">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sano</surname><given-names>S</given-names></name>
<name><surname>Ishino</surname><given-names>K</given-names></name>
<name><surname>Kawada</surname><given-names>M</given-names></name>
<name><surname>Honjo</surname><given-names>O</given-names></name>
</person-group>. <article-title>Right ventricle–pulmonary artery shunt in first stage palliation of hypoplastic left heart syndrome</article-title>. <source>Semin Cardiovasc Surg Pediatr Card Surg Annu</source>. <year>2004</year>;<volume>7</volume>:<fpage>22</fpage>-<lpage>31</lpage>.</citation>
</ref>
<ref id="bibr18-1089253213488947">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ohye</surname><given-names>RG</given-names></name>
<name><surname>Sleeper</surname><given-names>LA</given-names></name>
<name><surname>Mahony</surname><given-names>L</given-names></name><etal/>
</person-group>; <collab>Pediatric Heart Network Investigators</collab>. <article-title>Comparison of shunt types in the Norwood procedure for single-ventricle lesions</article-title>. <source>N Engl J Med</source>. <year>2010</year>;<volume>362</volume>:<fpage>1980</fpage>-<lpage>1992</lpage>.</citation>
</ref>
<ref id="bibr19-1089253213488947">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Murtuza</surname><given-names>B</given-names></name>
<name><surname>Stumper</surname><given-names>O</given-names></name>
<name><surname>Wall</surname><given-names>D</given-names></name><etal/>
</person-group>. <article-title>The effect of morphologic subtype on outcomes following the Sano-Norwood procedure</article-title>. <source>Eur J Cardiothorac Surg</source>. <year>2012</year>;<volume>42</volume>:<fpage>787</fpage>-<lpage>793</lpage>.</citation>
</ref>
<ref id="bibr20-1089253213488947">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Oppido</surname><given-names>G</given-names></name>
<name><surname>Pace Napoleone</surname><given-names>C</given-names></name>
<name><surname>Turci</surname><given-names>S</given-names></name><etal/>
</person-group>. <article-title>Moderately hypothermic cardiopulmonary bypass and low-flow antegrade selective cerebral perfusion for neonatal aortic arch surgery</article-title>. <source>Ann Thorac Surg</source>. <year>2006</year>;<volume>82</volume>:<fpage>2233</fpage>-<lpage>2239</lpage>.</citation>
</ref>
<ref id="bibr21-1089253213488947">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Visconti</surname><given-names>KJ</given-names></name>
<name><surname>Rimmer</surname><given-names>D</given-names></name>
<name><surname>Gauvreau</surname><given-names>K</given-names></name><etal/>
</person-group>. <article-title>Regional low-flow perfusion versus circulatory arrest in neonates: one-year neurodevelopmental outcome</article-title>. <source>Ann Thorac Surg</source>. <year>2006</year>;<volume>82</volume>:<fpage>2207</fpage>-<lpage>2213</lpage>.</citation>
</ref>
<ref id="bibr22-1089253213488947">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gaynor</surname><given-names>JW</given-names></name>
<name><surname>Jarvik</surname><given-names>GP</given-names></name>
<name><surname>Bernbaum</surname><given-names>J</given-names></name><etal/>
</person-group>. <article-title>The relationship of postoperative electrographic seizures to neurodevelopmental outcome at 1 year of age after neonatal and infant cardiac surgery</article-title>. <source>J Thorac Cardiovasc Surg</source>. <year>2006</year>;<volume>131</volume>:<fpage>181</fpage>-<lpage>189</lpage>.</citation>
</ref>
<ref id="bibr23-1089253213488947">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stasik</surname><given-names>CN</given-names></name>
<name><surname>Gelehrter</surname><given-names>S</given-names></name>
<name><surname>Goldberg</surname><given-names>CS</given-names></name>
<name><surname>Bove</surname><given-names>EL</given-names></name>
<name><surname>Devaney</surname><given-names>EJ</given-names></name>
<name><surname>Ohye</surname><given-names>RG</given-names></name>
</person-group>. <article-title>Current outcomes and risk factors for the Norwood procedure</article-title>. <source>J Thorac Cardiovasc Surg</source>. <year>2006</year>;<volume>131</volume>:<fpage>412</fpage>-<lpage>417</lpage>.</citation>
</ref>
<ref id="bibr24-1089253213488947">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dent</surname><given-names>CL</given-names></name>
<name><surname>Spaeth</surname><given-names>JP</given-names></name>
<name><surname>Jones</surname><given-names>BV</given-names></name><etal/>
</person-group>. <article-title>Brain magnetic resonance imaging abnormalities after the Norwood procedure using regional cerebral perfusion</article-title>. <source>J Thorac Cardiovasc Surg</source>. <year>2005</year>;<volume>130</volume>:<fpage>1523</fpage>-<lpage>1530</lpage>.</citation>
</ref>
<ref id="bibr25-1089253213488947">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hannan</surname><given-names>RL</given-names></name>
<name><surname>Ybarra</surname><given-names>MA</given-names></name>
<name><surname>Ojito</surname><given-names>JW</given-names></name>
<name><surname>Alonso</surname><given-names>FA</given-names></name>
<name><surname>Rossi</surname><given-names>AF</given-names></name>
<name><surname>Burke</surname><given-names>RP</given-names></name>
</person-group>. <article-title>Complex neonatal single ventricle palliation using antegrade cerebral perfusion</article-title>. <source>Ann Thorac Surg</source>. <year>2006</year>;<volume>82</volume>:<fpage>1278</fpage>-<lpage>1285</lpage>.</citation>
</ref>
<ref id="bibr26-1089253213488947">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Griselli</surname><given-names>M</given-names></name>
<name><surname>McGuirk</surname><given-names>SP</given-names></name>
<name><surname>Stümper</surname><given-names>O</given-names></name><etal/>
</person-group>. <article-title>Influence of surgical strategies on outcome after the Norwood procedure</article-title>. <source>J Thorac Cardiovasc Surg</source>. <year>2006</year>;<volume>131</volume>:<fpage>418</fpage>-<lpage>426</lpage>.</citation>
</ref>
<ref id="bibr27-1089253213488947">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bautista-Hernandez</surname><given-names>V</given-names></name>
<name><surname>Marx</surname><given-names>GR</given-names></name>
<name><surname>Gauvreau</surname><given-names>K</given-names></name><etal/>
</person-group>. <article-title>Coarctectomy reduces neoaortic arch obstruction in hypoplastic left heart syndrome</article-title>. <source>J Thorac Cardiovasc Surg</source>. <year>2007</year>;<volume>133</volume>:<fpage>1540</fpage>-<lpage>1546</lpage>.</citation>
</ref>
<ref id="bibr28-1089253213488947">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Alsoufi</surname><given-names>B</given-names></name>
<name><surname>Bennetts</surname><given-names>J</given-names></name>
<name><surname>Verma</surname><given-names>S</given-names></name>
<name><surname>Caldarone</surname><given-names>CA</given-names></name>
</person-group>. <article-title>New development in the treatment of hypoplastic left heart syndrome</article-title>. <source>Pediatrics</source>. <year>2007</year>;<volume>119</volume>;<fpage>109</fpage>-<lpage>117</lpage>.</citation>
</ref>
<ref id="bibr29-1089253213488947">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pasquali</surname><given-names>SK</given-names></name>
<name><surname>Ohye</surname><given-names>RG</given-names></name>
<name><surname>Lu</surname><given-names>M</given-names></name><etal/>
</person-group>; <collab>Pediatric Heart Network Investigators</collab>. <article-title>Variation in perioperative care across center for infants undergoing the Norwood procedure</article-title>. <source>J Thorac Cardiovasc Surg</source>. <year>2012</year>;<volume>144</volume>:<fpage>915</fpage>-<lpage>921</lpage>.</citation>
</ref>
<ref id="bibr30-1089253213488947">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ohye</surname><given-names>RG</given-names></name>
<name><surname>Schonbeck</surname><given-names>JV</given-names></name>
<name><surname>Eghtesady</surname><given-names>P</given-names></name><etal/>
</person-group> <collab>Pediatric Heart Network Investigators</collab>. <article-title>Cause, timing, and location of death in the single ventricle reconstruction trial</article-title>. <source>J Thorac Cardiovasc Surg</source>. <year>2012</year>;<volume>144</volume>:<fpage>907</fpage>-<lpage>914</lpage>.</citation>
</ref>
<ref id="bibr31-1089253213488947">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sarajuuri</surname><given-names>A</given-names></name>
<name><surname>Jokinen</surname><given-names>E</given-names></name>
<name><surname>Puosi</surname><given-names>R</given-names></name><etal/>
</person-group>. <article-title>Neurodevelopment and neuroradiologic outcomes in patients with univentricular heart aged 5 to 7 years: related risk factor analysis</article-title>: <source>J Thorac Surg</source>. <year>2007</year>;<volume>133</volume>:<fpage>1524</fpage>-<lpage>1532</lpage>.</citation>
</ref>
<ref id="bibr32-1089253213488947">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kelleher</surname><given-names>DK</given-names></name>
<name><surname>Laussen</surname><given-names>P</given-names></name>
<name><surname>Teixeira-Pinto</surname><given-names>A</given-names></name>
<name><surname>Duggan</surname><given-names>C</given-names></name>
</person-group>. <article-title>Growth and correlates of nutritional status among infants with hypoplastic left heart syndrome (HLHS) after stage 1 Norwood procedure</article-title>. <source>Nutrition</source>. <year>2006</year>;<volume>22</volume>:<fpage>237</fpage>-<lpage>244</lpage>.</citation>
</ref>
<ref id="bibr33-1089253213488947">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jeffries</surname><given-names>HE</given-names></name>
<name><surname>Wells</surname><given-names>WJ</given-names></name>
<name><surname>Starnes</surname><given-names>VA</given-names></name>
<name><surname>Wetzel</surname><given-names>RC</given-names></name>
<name><surname>Moromisato</surname><given-names>DY</given-names></name>
</person-group>. <article-title>Gastrointestinal morbidity after Norwood palliation for hypoplastic left heart syndrome</article-title>. <source>Ann Thorac Surg</source>. <year>2006</year>;<volume>81</volume>:<fpage>982</fpage>-<lpage>987</lpage>.</citation>
</ref>
<ref id="bibr34-1089253213488947">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jeffries</surname><given-names>HE</given-names></name>
<name><surname>Wells</surname><given-names>WJ</given-names></name>
<name><surname>Starnes</surname><given-names>VA</given-names></name>
<name><surname>Wetzel</surname><given-names>RC</given-names></name>
<name><surname>Moromisato</surname><given-names>DY</given-names></name>
</person-group>. <article-title>Gastrointestinal morbidity after Norwood palliation for hypoplastic left heart syndrome</article-title>. <source>Ann Thorac Surg</source>. <year>2006</year>;<volume>81</volume>:<fpage>982</fpage>-<lpage>987</lpage>.</citation>
</ref>
<ref id="bibr35-1089253213488947">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Muthurangu</surname><given-names>V</given-names></name>
<name><surname>Taylor</surname><given-names>AM</given-names></name>
<name><surname>Hegde</surname><given-names>SR</given-names></name><etal/>
</person-group>. <article-title>Cardiac magnetic resonance imaging after stage 1 Norwood operation for hypoplastic left heart syndrome</article-title>. <source>Circulation</source>. <year>2005</year>;<volume>112</volume>:<fpage>3256</fpage>-<lpage>3263</lpage>.</citation>
</ref>
<ref id="bibr36-1089253213488947">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Scheurer</surname><given-names>MA</given-names></name>
<name><surname>Hill</surname><given-names>EG</given-names></name>
<name><surname>Vasuki</surname><given-names>N</given-names></name><etal/>
</person-group>. <article-title>Survival after bidirectional cavopulmonary anastomosis: analysis of preoperative risk factors</article-title>. <source>J Thorac Cardiovasc Surg</source>. <year>2007</year>;<volume>134</volume>:<fpage>82</fpage>-<lpage>89</lpage>.</citation>
</ref>
<ref id="bibr37-1089253213488947">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Elmi</surname><given-names>M</given-names></name>
<name><surname>Hickey</surname><given-names>EJ</given-names></name>
<name><surname>Williams</surname><given-names>WG</given-names></name>
<name><surname>Van Arsdell</surname><given-names>G</given-names></name>
<name><surname>Caldarone</surname><given-names>CA</given-names></name>
<name><surname>McCrindle</surname><given-names>BW</given-names></name>
</person-group>. <article-title>Long-term tricuspid valve function after Norwood operation</article-title>. <source>J Thorac Cardiovasc Surg</source>. <year>2011</year>;<volume>142</volume>:<fpage>1341</fpage>-<lpage>1347</lpage>.</citation>
</ref>
<ref id="bibr38-1089253213488947">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ugaki</surname><given-names>S</given-names></name>
<name><surname>Khoo</surname><given-names>NS</given-names></name>
<name><surname>Ross</surname><given-names>DB</given-names></name>
<name><surname>Rebeyka</surname><given-names>IM</given-names></name>
<name><surname>Adatia</surname><given-names>I</given-names></name>
</person-group>. <article-title>Tricuspid valve repair improves early right ventricular and tricuspid valve remodeling in patients with hypoplastic left heart syndrome</article-title>. <source>J Thorac Cardiovasc Surg</source>. <year>2013</year>;<volume>145</volume>:<fpage>446</fpage>-<lpage>450</lpage>.</citation>
</ref>
<ref id="bibr39-1089253213488947">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fontan</surname><given-names>F</given-names></name>
<name><surname>Baudet</surname><given-names>E</given-names></name>
</person-group>. <article-title>Surgical repair of tricuspid atresia</article-title>. <source>Thorax</source>. <year>1971</year>;<volume>26</volume>:<fpage>240</fpage>-<lpage>248</lpage>.</citation>
</ref>
<ref id="bibr40-1089253213488947">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>de Leval</surname><given-names>MR</given-names></name>
<name><surname>Kilner</surname><given-names>P</given-names></name>
<name><surname>Gewillig</surname><given-names>M</given-names></name>
<name><surname>Bull</surname><given-names>C</given-names></name>
</person-group>. <article-title>Total cavopulmonary connection: a logical alternative to atriopulmonary connection for complex Fontan operations</article-title>. <source>J Thorac Cardiovasc Surg</source>. <year>1988</year>;<volume>96</volume>:<fpage>682</fpage>-<lpage>695</lpage>.</citation>
</ref>
<ref id="bibr41-1089253213488947">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Petrossian</surname><given-names>F</given-names></name>
<name><surname>Reddy</surname><given-names>VM</given-names></name>
<name><surname>McElhinney</surname><given-names>DB</given-names></name><etal/>
</person-group>. <article-title>Early results of the extracardiac conduit Fontan operation</article-title>. <source>J Thorac Cardiovasc Surg</source>. <year>1999</year>;<volume>117</volume>:<fpage>688</fpage>-<lpage>696</lpage>.</citation>
</ref>
<ref id="bibr42-1089253213488947">
<label>42.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Jonas</surname><given-names>RA</given-names></name>
<name><surname>DiNardo</surname><given-names>J</given-names></name>
<name><surname>Laussen</surname><given-names>PC</given-names></name>
<name><surname>Howe</surname><given-names>R</given-names></name>
<name><surname>LaPierre</surname><given-names>R</given-names></name>
<name><surname>Matte</surname><given-names>G</given-names></name>
</person-group>. <article-title>Hypoplastic left heart syndrome, single ventricle</article-title>. In: <source>Comprehensive Surgical Management of Congenital Heart Disease</source>. <publisher-loc>London, England</publisher-loc>: <publisher-name>Hodder Arnold</publisher-name>; <volume>2004</volume>:<fpage>341</fpage>-<lpage>385</lpage>.</citation>
</ref>
<ref id="bibr43-1089253213488947">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pizarro</surname><given-names>C</given-names></name>
<name><surname>Derby</surname><given-names>CD</given-names></name>
<name><surname>Baffa</surname><given-names>JM</given-names></name>
<name><surname>Murdison</surname><given-names>KA</given-names></name>
<name><surname>Radtke</surname><given-names>WA</given-names></name>
</person-group>. <article-title>Improving the outcome of high-risk neonates with hypoplastic left heart syndrome: hybrid procedure or conventional surgical palliation</article-title>. <source>Eur J Cardiothorac Surg</source>. <year>2008</year>;<volume>33</volume>:<fpage>613</fpage>-<lpage>618</lpage>.</citation>
</ref>
<ref id="bibr44-1089253213488947">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bacha</surname><given-names>EA</given-names></name>
<name><surname>Daves</surname><given-names>S</given-names></name>
<name><surname>Hardin</surname><given-names>J</given-names></name><etal/>
</person-group>. <article-title>Single-ventricle palliation for high-risk neonates: the emergence of an alternative hybrid stage 1 strategy</article-title>. <source>J Thorac Cardiovasc Surg</source>. <year>2006</year>;<volume>131</volume>:<fpage>163</fpage>-<lpage>171</lpage>.</citation>
</ref>
<ref id="bibr45-1089253213488947">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Caldarone</surname><given-names>CA</given-names></name>
<name><surname>Benson</surname><given-names>L</given-names></name>
<name><surname>Holtby</surname><given-names>H</given-names></name>
<name><surname>Li</surname><given-names>J</given-names></name>
<name><surname>Redington</surname><given-names>AN</given-names></name>
<name><surname>Van Arsdell</surname><given-names>GS</given-names></name>
</person-group>. <article-title>Initial experience with hybrid palliation for neonates with single-ventricle physiology</article-title>. <source>Ann Thorac Surg</source>. <year>2007</year>;<volume>84</volume>:<fpage>1294</fpage>-<lpage>1300</lpage>.</citation>
</ref>
<ref id="bibr46-1089253213488947">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Baba</surname><given-names>K</given-names></name>
<name><surname>Kotani</surname><given-names>Y</given-names></name>
<name><surname>Chetan</surname><given-names>D</given-names></name><etal/>
</person-group>. <article-title>Hybrid versus Norwood strategies for single-ventricle palliation</article-title>. <source>Circulation</source>. <year>2012</year>;<volume>126</volume>(<supplement>suppl 1</supplement>):<fpage>S123</fpage>-<lpage>S131</lpage>.</citation>
</ref>
<ref id="bibr47-1089253213488947">
<label>47.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ghanayem</surname><given-names>NS</given-names></name>
<name><surname>Allen</surname><given-names>KR</given-names></name>
<name><surname>Tabbutt</surname><given-names>S</given-names></name><etal/>
</person-group>; <collab>Pediatric Heart Network Investigators</collab>. <article-title>Interstage mortality after the Norwood procedure: results of the multicenter single ventricle reconstruction trial</article-title>. <source>J Thorac Cardiovasc Surg</source>. <year>2012</year>;<volume>144</volume>:<fpage>896</fpage>-<lpage>906</lpage>.</citation>
</ref>
<ref id="bibr48-1089253213488947">
<label>48.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chu</surname><given-names>MW</given-names></name>
<name><surname>Sharma</surname><given-names>K</given-names></name>
<name><surname>Tchervenkov</surname><given-names>CI</given-names></name><etal/>
</person-group>. <article-title>Berlin heart ventricular assist device in a child with hypoplastic left heart syndrome</article-title>. <source>Ann Thorac Surg</source>. <year>2007</year>;<volume>83</volume>:<fpage>1179</fpage>-<lpage>1181</lpage>.</citation>
</ref>
<ref id="bibr49-1089253213488947">
<label>49.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chrisant</surname><given-names>MR</given-names></name>
<name><surname>Naftel</surname><given-names>DC</given-names></name>
<name><surname>Drummond-Webb</surname><given-names>J</given-names></name><etal/>
</person-group>; <collab>Pediatric Heart Transplant Study Group</collab>. <article-title>Fate of infants with hypoplastic left heart syndrome listed for cardiac transplantation: a multicenter study</article-title>. <source>J Heart Lung Transplant</source>. <year>2005</year>;<volume>24</volume>:<fpage>576</fpage>-<lpage>582</lpage>.</citation>
</ref>
<ref id="bibr50-1089253213488947">
<label>50.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Artrip</surname><given-names>JH</given-names></name>
<name><surname>Campbell</surname><given-names>DN</given-names></name>
<name><surname>Ivy</surname><given-names>DD</given-names></name><etal/>
</person-group>. <article-title>Birth weight and complexity are significant factors for the management of hypoplastic left heart syndrome</article-title>. <source>Ann Thorac Surg</source>. <year>2006</year>;<volume>82</volume>:<fpage>1252</fpage>-<lpage>1259</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>